TIDMTTM
RNS Number : 6280D
J.P. Morgan Securities LLC
20 February 2020
Ap27
AMMENT
FORM 38.5(b)
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 38.5(b) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITHOUT
RECOGNISED INTERMEDIARY STATUS, OR WITH RECOGNISED
INTERMEDIARY STATUS BUT NOT DEALING IN A CLIENT-SERVING CAPACITY
1. KEY INFORMATION
Name of exempt principal J.P Morgan Securities LLC
trader
Company dealt in AbbVie Inc.
=========================
Class of relevant security Common stock
to which the dealings
being disclosed relate
(Note 1)
=========================
Date of dealing 18 February 2020
=========================
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the
class of relevant
security dealt in (Note 2)
Long Short
Number (%) Number (%)
========= ====== =========== ======
14,160,811 3,853,829
(1) Relevant securities 0.96 0.26
================= ===================
(2) Derivatives (other 2,531,009
than options) 3,405,762 0.23 0.17
================= ===================
(3) Options and agreements
to purchase/sell 886,400 0.06 738,400 0.05
================= ===================
18,452,973 7,123,238
Total 1.25 0.48
================= ===================
(b) Interests and short positions in relevant securities of the
company, other than the class dealt
in (Note 2)
Class of relevant security: Long Short
Number (%) Number (%)
========= ====== =========== ======
(1) Relevant securities
=================== =====================
(2) Derivatives (other
than options)
=================== =====================
(3) Options and agreements
to purchase/sell
=================== =====================
Total
=================== =====================
Ap28
3. DEALINGS (Note 3)
(a) Purchases and sales
Purchase/sale Number of relevant securities Price per unit
(Note 4)
Sale (Borrow 165,100 NA
Return)
75 93.3056 USD
Purchases 100 93.3168 USD
100 93.3454 USD
100 93.4051 USD
100 93.4338 USD
34 93.4403 USD
100 93.4800 USD
100 93.4885 USD
5 93.5000 USD
100 93.5095 USD
100 93.5100 USD
100 93.5144 USD
100 93.5157 USD
100 93.5230 USD
100 93.5341 USD
100 93.5362 USD
43 93.5408 USD
100 93.5764 USD
10 93.5770 USD
50 93.5794 USD
200 93.5847 USD
100 93.5971 USD
15,433 93.6100 USD
100 93.6115 USD
4 93.6125 USD
100 93.6242 USD
100 93.6297 USD
100 93.6300 USD
112 93.6400 USD
25 93.6436 USD
100 93.6478 USD
170 93.6600 USD
100 93.6737 USD
100 93.6768 USD
50 93.6893 USD
7,438 93.6916 USD
100 93.7156 USD
100 93.7439 USD
100 93.7492 USD
33 93.7565 USD
34 93.7584 USD
100 93.7847 USD
100 93.7906 USD
100 93.8017 USD
50 93.8082 USD
200 93.8216 USD
36 93.8222 USD
100 93.8299 USD
56 93.8307 USD
92 93.8362 USD
100 93.8383 USD
45 93.8684 USD
29 93.8804 USD
200 93.8907 USD
18 93.8922 USD
100 93.9000 USD
300 93.9033 USD
50 93.9163 USD
100 93.9303 USD
128 94.0100 USD
340 94.1541 USD
100 94.3800 USD
3 93.3200 USD
Sales 101 93.4800 USD
92 93.4985 USD
2 93.5100 USD
43 93.5142 USD
122 93.5336 USD
44 93.5389 USD
2 93.5400 USD
7 93.5600 USD
1 93.5700 USD
3 93.5800 USD
1 93.6000 USD
118,556 93.6100 USD
4 93.6125 USD
8 93.6200 USD
3 93.6300 USD
1 93.6500 USD
6 93.6600 USD
2,957 93.6630 USD
156 93.6699 USD
6 93.6800 USD
554 93.6900 USD
7,438 93.6916 USD
83 93.7061 USD
3,981 93.7112 USD
37 93.7168 USD
203 93.7400 USD
20 93.7475 USD
1 93.7500 USD
7 93.7600 USD
2 93.7700 USD
69 93.7819 USD
2 93.7900 USD
1 93.8000 USD
4 93.8100 USD
2 93.8200 USD
5 93.8300 USD
50 93.8344 USD
1 93.8500 USD
200 93.8550 USD
5 93.8600 USD
1 93.8800 USD
6 93.8900 USD
3 93.9100 USD
2 93.9200 USD
8 93.9300 USD
128 94.0100 USD
170 94.1541 USD
==================================== ===================
(b) Derivatives transactions (other than options transactions)
Product Nature of transaction Number of relevant Price per
name, securities unit
e.g. CFD (Note 5) (Note 6) (USD)
(Note 4)
Equity Swaps Long 105,700 93.6100
7,438 93.6916
Short 4 93.6125
170 94.1541
====================== =================== ==========
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product Writing, Number of Exercise Type, Expiry Option
name, selling, securities price e.g. American, date money paid/received
e.g. call purchasing, to which European per unit
option varying the option etc. (Note 4)
etc. relates (Note
7)
(ii) Exercising
Product name, Number of securities Exercise price
e.g. call option per unit (Note
4)
(d) Other dealings (including transactions in respect of new
securities) (Note 3)
Nature of transaction Details Price per unit
(Note 7) (if applicable)
(Note 4)
Ap29
4. OTHER INFORMATION
Agreements, arrangements or understandings relating to options
or derivatives
Full details of any agreement, arrangement or understanding
between the person disclosing and any other person relating to the
voting rights of any relevant securities under any option referred
to on this form or relating to the voting rights or future
acquisition or disposal of any relevant securities to which any
derivative referred to on this form is referenced. If
none, this should be stated.
Is a Supplemental Form 38.5(b) attached? (Note 8) YES
Date of disclosure 20 February 2020
Contact name Alwyn Basch
=============================
Telephone number 020 7742 7407
=============================
Name of offeree/offeror Allergan plc
with which connected
=============================
Nature of connection (Note Financial Advisor to Allergan
9) plc
=============================
Ap31
SUPPLEMENTAL FORM 38.5(b)
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 38.5(b) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DETAILS OF OPEN POSITIONS
(This form should be attached to Form 38.5(b)) OPEN POSITIONS (Note 1)
Product Written Number of Exercise Type, e.g. Expiry
name, or purchased relevant price American, date
e.g. call securities (Note European
option to which 2) etc.
the option
or derivative
relates
Put Option Written 87,500 60.00 American 21FEB20
Put Option Written 87,500 55.00 American 21FEB20
Put Option Written 102,500 60.00 American 19JUN20
Put Option Written 29,100 55.00 American 19JUN20
Put Option Written 31,300 65.00 American 19JUN20
Put Option Written 32,300 70.00 American 19JUN20
Put Option Written 11,400 75.00 American 19JUN20
Put Option Written 8,900 77.50 American 19JUN20
Put Option Written 1,900 72.50 American 19JUN20
Put Option Written 4,400 67.50 American 19JUN20
Put Option Written 20,000 60.00 American 15JAN21
Put Option Written 100,000 70.00 American 15JAN21
Put Option Written 15,000 78.49 American 15JAN21
Put Option Written 15,000 82.85 American 15JAN21
Put Option Purchased 102,500 60.00 American 19JUN20
Put Option Purchased 29,100 55.00 American 19JUN20
Put Option Purchased 31,300 65.00 American 19JUN20
Put Option Purchased 32,300 70.00 American 19JUN20
Put Option Purchased 16,400 75.00 American 19JUN20
Put Option Purchased 85,400 77.50 American 19JUN20
Put Option Purchased 900 85.00 American 19JUN20
Put Option Purchased 7,000 72.50 American 19JUN20
Put Option Purchased 4,400 67.50 American 19JUN20
Put Option Purchased 45,000 80.00 American 19JUN20
Put Option Purchased 9,700 60.00 American 15JAN21
Put Option Purchased 4,900 65.00 American 15JAN21
Put Option Purchased 12,100 70.00 American 15JAN21
Put Option Purchased 12,100 75.00 American 15JAN21
Put Option Purchased 800 77.50 American 15JAN21
Put Option Purchased 140,000 82.50 American 15JAN21
Put Option Purchased 5,100 62.50 American 15JAN21
Put Option Purchased 3,000 72.50 American 15JAN21
Put Option Purchased 600 67.50 American 15JAN21
Put Option Purchased 20,000 80.00 American 15JAN21
Put Option Purchased 15,000 78.49 American 15JAN21
Put Option Purchased 15,000 82.85 American 15JAN21
Call Option Written 8,500 105.00 American 19JUN20
Call Option Written 6,100 110.00 American 19JUN20
Call Option Written 18,200 85.00 American 19JUN20
Call Option Written 8,400 92.50 American 19JUN20
Call Option Written 11,200 95.00 American 19JUN20
Call Option Written 7,200 100.00 American 19JUN20
Call Option Written 21,100 80.00 American 19JUN20
Call Option Written 2,500 87.50 American 19JUN20
Call Option Written 4,500 90.00 American 19JUN20
Call Option Written 5,600 97.50 American 19JUN20
Call Option Written 2,500 115.00 American 19JUN20
Call Option Written 20,000 82.50 American 15JAN21
Call Option Written 15,000 91.57 American 15JAN21
Call Option Written 15,000 95.93 American 15JAN21
Call Option Purchased 10,000 105.00 American 19JUN20
Call Option Purchased 6,100 110.00 American 19JUN20
Call Option Purchased 41,200 85.00 American 19JUN20
Call Option Purchased 8,400 92.50 American 19JUN20
Call Option Purchased 11,200 95.00 American 19JUN20
Call Option Purchased 7,200 100.00 American 19JUN20
Call Option Purchased 21,100 80.00 American 19JUN20
Call Option Purchased 2,500 87.50 American 19JUN20
Call Option Purchased 7,900 90.00 American 19JUN20
Call Option Purchased 5,600 97.50 American 19JUN20
Call Option Purchased 2,500 115.00 American 19JUN20
Call Option Purchased 8,500 105.00 American 15JAN21
Call Option Purchased 10,000 110.00 American 15JAN21
Call Option Purchased 100,000 70.00 American 15JAN21
Call Option Purchased 50,000 92.50 American 15JAN21
Call Option Purchased 15,000 91.57 American 15JAN21
Call Option Purchased 15,000 95.93 American 15JAN21
Call Option Purchased 7,900 95.00 American 18SEP20
Call Option Purchased 9,500 100.00 American 18SEP20
============== =============== ========= =========== ========
Notes
1. Where there are open option positions or open derivative
positions (except for CFDs), full details should be given. Full
details of any existing agreements to purchase or to sell must also
be given on this form.
2. For all prices and other monetary amounts, the currency must be stated.
For full details of disclosur e requirements, see Rules 8 and
38.5 of the Rules. If in doubt, consult the Panel.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
ISESEAFFSESSEEE
(END) Dow Jones Newswires
February 20, 2020 06:32 ET (11:32 GMT)